Welcome to the second edition of our new look newsletter Spot News.
Read More
Welcome to the second edition of our new look newsletter Spot News.
Read More
5 July 2019, Merck Sharp & Dohme (New Zealand) Limited (MSD) today announced that KEYTRUDA® (pembrolizumab) has been registered for the treatment of patients with stage III melanoma (melanoma removed surgically, with cancer found in the lymph nodes). Currently it is registered and funded for patients with advanced or metastatic melanoma.
Read More
Welcome to the first edition of our new look newsletter Spot News.
Read More
CANGO calls on this Government to urgently consider and implement changes for reasons of equity, evidence and deep concerns about the systemic underfunding of more effective cancer treatments.
Read More
Chief Executive Announcement
Melanoma New Zealand is delighted to announce the appointment of Andrea Newland as its new Chief Executive.
Read More
Support our worthwhile cause and buy a t-shirt
Read More
On that hot sunny day at Eden Park watching the cricket in ‘82, or chilling to the beats at Sweetwaters in ‘81, Melanoma was there too…
Read More
Go Spotty Day - A dedicated day to get people in the community thinking about melanoma and checking their skin for ‘spots’ or signs that could save lives.
Read More
Leo Zeldenrust always knew he had a lot of moles but it was not until 2014 that he noticed one of them had started to look a bit different. His doctor thought it was a wart so she blitzed it with nitrogen and it was gone.
Read More
August 10, 2017
CANGO manifesto launch with colleagues from 9 prominent cancer organisations who have come together as an alliance because we believe kiwis deserve better.
Read More
In January 2007, I glanced at a tiny black ‘stain’, a fraction of the size of a pin head, on top of my left shoulder. I was not overly concerned about it, primarily because it was not giving me any problem.
Read More